Brief: Aurobindo Pharma Q1 Consol Net Profit 8.25 Bln Rupees
04/08/2025 15:28
Aug 4 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: Q1 CONSOL NET PROFIT 8.25 BILLION RUPEES Q1 CONSOL TOTAL REVENUE FROM OPERATIONS 78.68 BILLION RUPEES DIVIDEND 4 RUPEES PER SHARE Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11